FDA 483 - Kettering Medical Center - May 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Kettering Medical Center, a PET drug manufacturer in Kettering, OH, revealed significant deficiencies in quality assurance and production oversight. The firm failed to ensure adequate personnel for QA functions, maintain unique and accurate batch production records, and conduct thorough investigations into failed or aborted batches. These issues indicate a lack of control over PET drug manufacturing processes, potentially impacting product safety, identity, strength, quality, and purity.
ID · 44cfa4cb-cca0-4bc2-a109-0ac334c07cb9